Genotype-agnostic rescue of cystic fibrosis with small molecule bicarbonate channels
US12090164B2 · kind B2 · utility
1Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 11, 2018 |
| Grant date | Sep 17, 2024 |
| Priority date | — |
| Expiry date | Oct 31, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of treating cystic fibrosis using AmB and a sterol or compositions comprising AmB and a sterol. Also disclosed are methods of increasing the pH of airway surface liquid in a patient having cystic fibrosis using AmB and a sterol; and methods of decreasing the viscosity of airway surface liquid in a patient having cystic fibrosis using AmB and a sterol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.